In Ventiv Health Inc is categorized under Commercial Medical Research in Houston, TX .
In Ventiv Health Inc was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 5417112 by the NAICS.
If you are seeking more information, feel free to contact Michael Hlinak, Chief Executive Officer at the company’s branch by writing to 16225 Park Ten Place # 200, Houston, Texas TX 77084 or by phoning (281) 829-1110. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | In Ventiv Health Inc |
| Contact Person: | Michael Hlinak, Chief Executive Officer |
| Address: | 16225 Park Ten Place # 200, Houston, Texas 77084 |
| Phone Number: | (281) 829-1110 |
| Website Address: | inventivhealth.com |
| Annual Revenue (USD): | Unknown |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 5417112 |
| Share This Business: |
In Ventiv Health Inc was started in 0 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 5417112. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Michael Hlinak, Chief Executive Officer for inquiries that concern In Ventiv Health Inc by calling the company number (281) 829-1110, as your correspondence is most welcome. Additionally, the physical location of the branch of In Ventiv Health Inc can be found at the coordinates 29.786745,-95.664165 as well as the street address 16225 Park Ten Place # 200 in Houston, Texas 77084.
For its online presence, you may visit In Ventiv Health Inc’s website at inventivhealth.com and engage with its social media outlets through on Twitter and on Facebook.